SPL 1.60% 9.6¢ starpharma holdings limited

Ann: DEP HER2-lutetium outperforms in human breast cancer model, page-28

  1. 2,841 Posts.
    lightbulb Created with Sketch. 139
    Sarge, you missed the line above that one written in capital letters in AB's comment:

    "IN MY OPINION ONLY"

    Perhaps more productive to focus on the present instead of comments from two years ago? Can I also suggest that you might like to focus on the stock instead of fixating on other posters?
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.